Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 5 studies | 31% ± 14% | |
ciliated cell | 3 studies | 25% ± 7% |
Insufficient scRNA-seq data for expression of NUDT15 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 755.52 | 180 / 180 | 100% | 41.69 | 430 / 430 |
uterus | 100% | 721.15 | 170 / 170 | 100% | 51.96 | 459 / 459 |
bladder | 100% | 754.24 | 21 / 21 | 100% | 48.07 | 503 / 504 |
prostate | 100% | 1023.27 | 245 / 245 | 100% | 36.64 | 501 / 502 |
breast | 100% | 910.67 | 459 / 459 | 100% | 35.03 | 1115 / 1118 |
lung | 100% | 807.54 | 576 / 578 | 100% | 40.34 | 1155 / 1155 |
intestine | 100% | 900.80 | 966 / 966 | 99% | 60.67 | 524 / 527 |
esophagus | 100% | 893.96 | 1444 / 1445 | 99% | 39.39 | 182 / 183 |
stomach | 100% | 682.97 | 359 / 359 | 99% | 51.87 | 284 / 286 |
thymus | 100% | 987.76 | 653 / 653 | 99% | 30.20 | 598 / 605 |
pancreas | 99% | 538.15 | 326 / 328 | 99% | 31.36 | 177 / 178 |
kidney | 100% | 1187.51 | 89 / 89 | 99% | 27.56 | 890 / 901 |
brain | 100% | 709.36 | 2631 / 2642 | 99% | 17.07 | 699 / 705 |
skin | 100% | 1151.58 | 1807 / 1809 | 98% | 35.73 | 463 / 472 |
adrenal gland | 100% | 1020.84 | 258 / 258 | 96% | 21.84 | 221 / 230 |
liver | 100% | 596.69 | 226 / 226 | 94% | 16.80 | 383 / 406 |
adipose | 100% | 900.84 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 542.81 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 44.06 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 18.88 | 1 / 1 |
muscle | 100% | 687.16 | 801 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 630.98 | 1330 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 634.32 | 844 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 21.19 | 28 / 29 |
eye | 0% | 0 | 0 / 0 | 91% | 17.90 | 73 / 80 |
peripheral blood | 46% | 339.78 | 424 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0055086 | Biological process | nucleobase-containing small molecule metabolic process |
GO_1901292 | Biological process | nucleoside phosphate catabolic process |
GO_0006195 | Biological process | purine nucleotide catabolic process |
GO_0042178 | Biological process | xenobiotic catabolic process |
GO_0042262 | Biological process | DNA protection |
GO_0000278 | Biological process | mitotic cell cycle |
GO_0006203 | Biological process | dGTP catabolic process |
GO_0061136 | Biological process | regulation of proteasomal protein catabolic process |
GO_0000302 | Biological process | response to reactive oxygen species |
GO_0005829 | Cellular component | cytosol |
GO_0008413 | Molecular function | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity |
GO_0035539 | Molecular function | 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity |
GO_0044715 | Molecular function | 8-oxo-dGDP phosphatase activity |
GO_0005515 | Molecular function | protein binding |
GO_0047429 | Molecular function | nucleoside triphosphate diphosphatase activity |
GO_0046872 | Molecular function | metal ion binding |
Gene name | NUDT15 |
Protein name | Nucleotide triphosphate diphosphatase NUDT15 (EC 3.6.1.9) (MutT homolog 2) (MTH2) (Nucleoside diphosphate-linked moiety X motif 15) (Nudix motif 15) (Nucleoside diphosphate-linked to another moiety X hydrolase 15) (Nudix hydrolase 15) |
Synonyms | MTH2 |
Description | FUNCTION: May catalyze the hydrolysis of nucleoside triphosphates including dGTP, dTTP, dCTP, their oxidized forms like 8-oxo-dGTP and the prodrug thiopurine derivatives 6-thio-dGTP and 6-thio-GTP . Could also catalyze the hydrolysis of some nucleoside diphosphate derivatives . Hydrolyzes oxidized nucleosides triphosphates like 8-oxo-dGTP in vitro, but the specificity and efficiency towards these substrates are low. Therefore, the potential in vivo sanitizing role of this enzyme, that would consist in removing oxidatively damaged forms of nucleosides to prevent their incorporation into DNA, is unclear . Through the hydrolysis of thioguanosine triphosphates may participate in the catabolism of thiopurine drugs . May also have a role in DNA synthesis and cell cycle progression by stabilizing PCNA . Exhibits decapping activity towards dpCoA-capped RNAs in vitro (By similarity). . |
Accessions | ENST00000258662.3 Q9NV35 |